RNS Number : 7977N
Bowleven plc
09 May 2024
 

 

 

 


9 May 2024

 

 

Bowleven plc ('Bowleven')

Block Admission Six Monthly Return

                                                                                        

This Block Admission Six Monthly Return is intended to comply with the requirements of AIM Rule 29 and Schedule Six.

 

Name of company:

BOWLEVEN PLC

Name of scheme:

1)  BOWLEVEN PLC APPROVED CSOP SCHEME        (WITH UNAPPROVED SCHEDULE)

2)  BOWLEVEN PLC SCHEDULE 4 CSOP SCHEME        (WITH UNAPPROVED SCHEDULE)

Period of return:

From:

9 NOVEMBER 2023

To:

8 MAY 2024

Balance of unallotted securities under scheme(s) from previous return:

659,526

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period:

NIL

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

659,526

Number and class of share(s) (amount of stock/debit securities) originally admitted and the Date of Admission:

852,105 ORDINARY SHARES

9 MAY 2018

Total number of shares in issue at the end of the period:

1,897,772,933

 

 

ENQUIRIES

 

For further information, please contact:

 

Bowleven plc


Eli Chahin, Chief Executive

00 44 20 3327 0150



Camarco (Financial PR)


Owen Roberts

00 44 20 3757 4980

Hugo Liddy




Shore Capital (NOMAD and Broker)



00 44 20 7408 4090

Daniel Bush

Rachel Goldstein


 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRKZGGKRLGGDZG